Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Targeting Foxp3 Tumor Intrinsic Effects Using Adenoviral Vectors in Experimental Breast Cancer

Alejandro Javier Nicola Candia
ORCID logo ,
Matias Garcia Fallit
,
Jorge Armando Peña Agudelo
ORCID logo ,
Melanie Perez Kuper
,
Nazareno Gonzalez
,
Mariela Alejandra Moreno Ayala
,
Emilio De Simone
,
Carla Giampaoli
,
Noelia Casares
,
Adriana Seilicovich
,
Juan José Lasarte
ORCID logo ,
Flavia Adriana Zanetti
ORCID logo ,
Marianela Candolfi
*
Version 1 : Received: 31 July 2023 / Approved: 1 August 2023 / Online: 2 August 2023 (02:27:23 CEST)

A peer-reviewed article of this Preprint also exists.

Nicola Candia, A.J.; Garcia Fallit, M.; Peña Agudelo, J.A.; Pérez Küper, M.; Gonzalez, N.; Moreno Ayala, M.A.; De Simone, E.; Giampaoli, C.; Casares, N.; Seilicovich, A.; Lasarte, J.J.; Zanetti, F.A.; Candolfi, M. Targeting FOXP3 Tumor-Intrinsic Effects Using Adenoviral Vectors in Experimental Breast Cancer. Viruses 2023, 15, 1813. Nicola Candia, A.J.; Garcia Fallit, M.; Peña Agudelo, J.A.; Pérez Küper, M.; Gonzalez, N.; Moreno Ayala, M.A.; De Simone, E.; Giampaoli, C.; Casares, N.; Seilicovich, A.; Lasarte, J.J.; Zanetti, F.A.; Candolfi, M. Targeting FOXP3 Tumor-Intrinsic Effects Using Adenoviral Vectors in Experimental Breast Cancer. Viruses 2023, 15, 1813.

Abstract

Regulatory T cell master transcription factor, Forkhead box P3 (Foxp3) has been detected in cancer cells, but its role in breast tumor pathogenesis remains controversial. Here we assessed Foxp3 tumor intrinsic effects in experimental breast cancer using a Foxp3 binder peptide (P60) that impairs Foxp3 nuclear translocation. Cisplatin upregulated Foxp3 expression in HER2+ and triple negative breast cancer (TNBC) cells. Foxp3 inhibition with P60 enhanced chemosensitivity and reduced cell survival and migration in human and murine breast tumor cells. We also developed an adenoviral vector encoding P60 (Ad.P60) that efficiently transduced breast tumor cells, reduced cell viability and migration, and improved the cytotoxic response to cisplatin. Conditioned medium from transduced breast tumor cells contained lower levels of IL-10 and improved the activation of splenic lymphocytes. Intratumor administration of Ad.P60 in breast tumor-bearing mice significantly reduced tumor infiltration of Tregs, delayed tumor growth and inhibited the development of spontaneous lung metastases. Our results suggest that Foxp3 exerts protumoral intrinsic effects in breast cancer cells, and that gene therapy-mediated blockade of Foxp3 could constitute a therapeutic strategy to improve the response of these tumors to standard treatment.

Keywords

Foxp3; Cell Penetrating Peptide; Gene therapy; Breast cancer; Chemosensitivity

Subject

Medicine and Pharmacology, Oncology and Oncogenics

Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Download PDF Download Supplementary

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0
Get PDF Supplementary Files Cite Share 0
Bookmark BibSonomy Mendeley Reddit Delicious
×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.